Review



microarray analysis partek genome suite  (Partek)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Partek microarray analysis partek genome suite
    Microarray Analysis Partek Genome Suite, supplied by Partek, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/partek+microarray+suite/microarray+analysis+partek+genome+suite/pm29892064-598-11-5
    Average 90 stars, based on 1 article reviews
    microarray analysis partek genome suite - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    FACS:

    Article Title: The human heart contains distinct macrophage subsets with divergent origins and functions.
    Article Snippet: Software and code Policy information about availability of computer code Data collection data collection was performed manually Data analysis GraphPad Prism 7 and SAS for all statistical analyses. .. FlowJo v7.6.5. for FACS and Partek Genome Suite was used for microarray analysis For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. ..

    Microarray:

    Article Title: The human heart contains distinct macrophage subsets with divergent origins and functions.
    Article Snippet: Software and code Policy information about availability of computer code Data collection data collection was performed manually Data analysis GraphPad Prism 7 and SAS for all statistical analyses. .. FlowJo v7.6.5. for FACS and Partek Genome Suite was used for microarray analysis For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. ..

    Software:

    Article Title: The human heart contains distinct macrophage subsets with divergent origins and functions.
    Article Snippet: Software and code Policy information about availability of computer code Data collection data collection was performed manually Data analysis GraphPad Prism 7 and SAS for all statistical analyses. .. FlowJo v7.6.5. for FACS and Partek Genome Suite was used for microarray analysis For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. ..



    Similar Products

    microarray analysis partek genomics suite (v6.6)  (Partek)
    90
    Partek microarray analysis partek genomics suite (v6.6)
    Microarray Analysis Partek Genomics Suite (V6.6), supplied by Partek, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/partek+microarray+suite/microarray+analysis+partek+genomics+suite++v6+6+/pmc07445281-201-0-5
    Average 90 stars, based on 1 article reviews
    microarray analysis partek genomics suite (v6.6) - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    microarray results using a one-way anova model by partek genomics suite  (Partek)
    90
    Partek microarray results using a one-way anova model by partek genomics suite
    Microarray Results Using A One Way Anova Model By Partek Genomics Suite, supplied by Partek, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/partek+microarray+suite/microarray+results+using+a+one+way+anova+model+by+partek+genomics+suite/pmc07460550-119-16-18
    Average 90 stars, based on 1 article reviews
    microarray results using a one-way anova model by partek genomics suite - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    microarray analysis partek genome suite  (Partek)
    90
    Partek microarray analysis partek genome suite
    Microarray Analysis Partek Genome Suite, supplied by Partek, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/partek+microarray+suite/microarray+analysis+partek+genome+suite/pm29892064-598-11-5
    Average 90 stars, based on 1 article reviews
    microarray analysis partek genome suite - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    whole gene list generated by uploading the raw microarray data to partek genomics suite 6.6  (Partek)
    90
    Partek whole gene list generated by uploading the raw microarray data to partek genomics suite 6.6
    (A) IPA assay of CASZ1b targets in SY5Y cells determined by <t>microarray</t> showed gene enrichment in the categories of molecular and cellular functions with a key subcategory being cell growth and proliferation (threshold represents p=0.05). (B) GSEA assay indicated the positive enrichment of genes involved neurological system process (left panel), and negative enrichment of genes regulated by MYC (right panel). NES, normalized enrichment score; Nom, nominal; FDR, false discovery rate. (C) Transcriptional activity assay of cytoplasmic localized K37A mutant and loss of NuRD binding mutant L31A in SY5Y cells by realtime PCR. a, Left panel: western blot analysis of CASZ1b and mutant proteins from SY5YtetCASZ1b and CASZ1b mutant cells after 24 h Tet treatment; right panel: realtime PCR analysis of CASZ1b and mutant mRNA levels from SY5YtetCASZ1b and CASZ1b mutant cells after 24 h Tet treatment. b-f, realtime PCR result verified the regulation of TH, NGFR, CD9, MYC and KIT by CASZ1b in SY5Y cells after 24 h Tet treatment. Compared to wild type CASZ1b, K37 almost completely lost transcriptional activity at regulating all these genes in SY5Y cells (data are shown as means ± S.E.M., *: p<0.05). Compared to wild type CASZ1b, L37 significantly decreased transcriptional activity at regulating TH, NGFR and MYC, but had a slight increase at regulating CD9 and no effect on KIT (data are shown as means ± S.E.M., *: p<0.05).
    Whole Gene List Generated By Uploading The Raw Microarray Data To Partek Genomics Suite 6.6, supplied by Partek, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/partek+microarray+suite/whole+gene+list+generated+by+uploading+the+raw+microarray+data+to+partek+genomics+suite+6+6/pmc05140774-228-20-23
    Average 90 stars, based on 1 article reviews
    whole gene list generated by uploading the raw microarray data to partek genomics suite 6.6 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    cdna microarray partek genomics suite 6.6  (Partek)
    90
    Partek cdna microarray partek genomics suite 6.6
    (A) IPA assay of CASZ1b targets in SY5Y cells determined by <t>microarray</t> showed gene enrichment in the categories of molecular and cellular functions with a key subcategory being cell growth and proliferation (threshold represents p=0.05). (B) GSEA assay indicated the positive enrichment of genes involved neurological system process (left panel), and negative enrichment of genes regulated by MYC (right panel). NES, normalized enrichment score; Nom, nominal; FDR, false discovery rate. (C) Transcriptional activity assay of cytoplasmic localized K37A mutant and loss of NuRD binding mutant L31A in SY5Y cells by realtime PCR. a, Left panel: western blot analysis of CASZ1b and mutant proteins from SY5YtetCASZ1b and CASZ1b mutant cells after 24 h Tet treatment; right panel: realtime PCR analysis of CASZ1b and mutant mRNA levels from SY5YtetCASZ1b and CASZ1b mutant cells after 24 h Tet treatment. b-f, realtime PCR result verified the regulation of TH, NGFR, CD9, MYC and KIT by CASZ1b in SY5Y cells after 24 h Tet treatment. Compared to wild type CASZ1b, K37 almost completely lost transcriptional activity at regulating all these genes in SY5Y cells (data are shown as means ± S.E.M., *: p<0.05). Compared to wild type CASZ1b, L37 significantly decreased transcriptional activity at regulating TH, NGFR and MYC, but had a slight increase at regulating CD9 and no effect on KIT (data are shown as means ± S.E.M., *: p<0.05).
    Cdna Microarray Partek Genomics Suite 6.6, supplied by Partek, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/partek+microarray+suite/cdna+microarray+partek+genomics+suite+6+6/pm24059308-2-1-4
    Average 90 stars, based on 1 article reviews
    cdna microarray partek genomics suite 6.6 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    software applications for microarrays in partek genomics suite  (Partek)
    90
    Partek software applications for microarrays in partek genomics suite
    (A) IPA assay of CASZ1b targets in SY5Y cells determined by <t>microarray</t> showed gene enrichment in the categories of molecular and cellular functions with a key subcategory being cell growth and proliferation (threshold represents p=0.05). (B) GSEA assay indicated the positive enrichment of genes involved neurological system process (left panel), and negative enrichment of genes regulated by MYC (right panel). NES, normalized enrichment score; Nom, nominal; FDR, false discovery rate. (C) Transcriptional activity assay of cytoplasmic localized K37A mutant and loss of NuRD binding mutant L31A in SY5Y cells by realtime PCR. a, Left panel: western blot analysis of CASZ1b and mutant proteins from SY5YtetCASZ1b and CASZ1b mutant cells after 24 h Tet treatment; right panel: realtime PCR analysis of CASZ1b and mutant mRNA levels from SY5YtetCASZ1b and CASZ1b mutant cells after 24 h Tet treatment. b-f, realtime PCR result verified the regulation of TH, NGFR, CD9, MYC and KIT by CASZ1b in SY5Y cells after 24 h Tet treatment. Compared to wild type CASZ1b, K37 almost completely lost transcriptional activity at regulating all these genes in SY5Y cells (data are shown as means ± S.E.M., *: p<0.05). Compared to wild type CASZ1b, L37 significantly decreased transcriptional activity at regulating TH, NGFR and MYC, but had a slight increase at regulating CD9 and no effect on KIT (data are shown as means ± S.E.M., *: p<0.05).
    Software Applications For Microarrays In Partek Genomics Suite, supplied by Partek, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/partek+microarray+suite/partek+genomics+suite/pmc03912324-98-17-19
    Average 90 stars, based on 1 article reviews
    software applications for microarrays in partek genomics suite - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    robust microarray analysis routine partek genomics suite 6.5  (Partek)
    90
    Partek robust microarray analysis routine partek genomics suite 6.5
    (A) IPA assay of CASZ1b targets in SY5Y cells determined by <t>microarray</t> showed gene enrichment in the categories of molecular and cellular functions with a key subcategory being cell growth and proliferation (threshold represents p=0.05). (B) GSEA assay indicated the positive enrichment of genes involved neurological system process (left panel), and negative enrichment of genes regulated by MYC (right panel). NES, normalized enrichment score; Nom, nominal; FDR, false discovery rate. (C) Transcriptional activity assay of cytoplasmic localized K37A mutant and loss of NuRD binding mutant L31A in SY5Y cells by realtime PCR. a, Left panel: western blot analysis of CASZ1b and mutant proteins from SY5YtetCASZ1b and CASZ1b mutant cells after 24 h Tet treatment; right panel: realtime PCR analysis of CASZ1b and mutant mRNA levels from SY5YtetCASZ1b and CASZ1b mutant cells after 24 h Tet treatment. b-f, realtime PCR result verified the regulation of TH, NGFR, CD9, MYC and KIT by CASZ1b in SY5Y cells after 24 h Tet treatment. Compared to wild type CASZ1b, K37 almost completely lost transcriptional activity at regulating all these genes in SY5Y cells (data are shown as means ± S.E.M., *: p<0.05). Compared to wild type CASZ1b, L37 significantly decreased transcriptional activity at regulating TH, NGFR and MYC, but had a slight increase at regulating CD9 and no effect on KIT (data are shown as means ± S.E.M., *: p<0.05).
    Robust Microarray Analysis Routine Partek Genomics Suite 6.5, supplied by Partek, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/partek+microarray+suite/robust+microarray+analysis+routine+partek+genomics+suite+6+5/pmc04455926-68-14-13
    Average 90 stars, based on 1 article reviews
    robust microarray analysis routine partek genomics suite 6.5 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    microarrays produced by partek genomics suite software  (Partek)
    90
    Partek microarrays produced by partek genomics suite software
    (A) IPA assay of CASZ1b targets in SY5Y cells determined by <t>microarray</t> showed gene enrichment in the categories of molecular and cellular functions with a key subcategory being cell growth and proliferation (threshold represents p=0.05). (B) GSEA assay indicated the positive enrichment of genes involved neurological system process (left panel), and negative enrichment of genes regulated by MYC (right panel). NES, normalized enrichment score; Nom, nominal; FDR, false discovery rate. (C) Transcriptional activity assay of cytoplasmic localized K37A mutant and loss of NuRD binding mutant L31A in SY5Y cells by realtime PCR. a, Left panel: western blot analysis of CASZ1b and mutant proteins from SY5YtetCASZ1b and CASZ1b mutant cells after 24 h Tet treatment; right panel: realtime PCR analysis of CASZ1b and mutant mRNA levels from SY5YtetCASZ1b and CASZ1b mutant cells after 24 h Tet treatment. b-f, realtime PCR result verified the regulation of TH, NGFR, CD9, MYC and KIT by CASZ1b in SY5Y cells after 24 h Tet treatment. Compared to wild type CASZ1b, K37 almost completely lost transcriptional activity at regulating all these genes in SY5Y cells (data are shown as means ± S.E.M., *: p<0.05). Compared to wild type CASZ1b, L37 significantly decreased transcriptional activity at regulating TH, NGFR and MYC, but had a slight increase at regulating CD9 and no effect on KIT (data are shown as means ± S.E.M., *: p<0.05).
    Microarrays Produced By Partek Genomics Suite Software, supplied by Partek, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/partek+microarray+suite/partek+genomics+suite/pmc03386136-82-16-20
    Average 90 stars, based on 1 article reviews
    microarrays produced by partek genomics suite software - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    partek microarray suite  (Partek)
    90
    Partek partek microarray suite
    (A) IPA assay of CASZ1b targets in SY5Y cells determined by <t>microarray</t> showed gene enrichment in the categories of molecular and cellular functions with a key subcategory being cell growth and proliferation (threshold represents p=0.05). (B) GSEA assay indicated the positive enrichment of genes involved neurological system process (left panel), and negative enrichment of genes regulated by MYC (right panel). NES, normalized enrichment score; Nom, nominal; FDR, false discovery rate. (C) Transcriptional activity assay of cytoplasmic localized K37A mutant and loss of NuRD binding mutant L31A in SY5Y cells by realtime PCR. a, Left panel: western blot analysis of CASZ1b and mutant proteins from SY5YtetCASZ1b and CASZ1b mutant cells after 24 h Tet treatment; right panel: realtime PCR analysis of CASZ1b and mutant mRNA levels from SY5YtetCASZ1b and CASZ1b mutant cells after 24 h Tet treatment. b-f, realtime PCR result verified the regulation of TH, NGFR, CD9, MYC and KIT by CASZ1b in SY5Y cells after 24 h Tet treatment. Compared to wild type CASZ1b, K37 almost completely lost transcriptional activity at regulating all these genes in SY5Y cells (data are shown as means ± S.E.M., *: p<0.05). Compared to wild type CASZ1b, L37 significantly decreased transcriptional activity at regulating TH, NGFR and MYC, but had a slight increase at regulating CD9 and no effect on KIT (data are shown as means ± S.E.M., *: p<0.05).
    Partek Microarray Suite, supplied by Partek, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/partek+microarray+suite/partek+genomics+suite/10__1097_slash_01__pcc__0000295999__95099__cd-32-27-26
    Average 90 stars, based on 1 article reviews
    partek microarray suite - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) IPA assay of CASZ1b targets in SY5Y cells determined by microarray showed gene enrichment in the categories of molecular and cellular functions with a key subcategory being cell growth and proliferation (threshold represents p=0.05). (B) GSEA assay indicated the positive enrichment of genes involved neurological system process (left panel), and negative enrichment of genes regulated by MYC (right panel). NES, normalized enrichment score; Nom, nominal; FDR, false discovery rate. (C) Transcriptional activity assay of cytoplasmic localized K37A mutant and loss of NuRD binding mutant L31A in SY5Y cells by realtime PCR. a, Left panel: western blot analysis of CASZ1b and mutant proteins from SY5YtetCASZ1b and CASZ1b mutant cells after 24 h Tet treatment; right panel: realtime PCR analysis of CASZ1b and mutant mRNA levels from SY5YtetCASZ1b and CASZ1b mutant cells after 24 h Tet treatment. b-f, realtime PCR result verified the regulation of TH, NGFR, CD9, MYC and KIT by CASZ1b in SY5Y cells after 24 h Tet treatment. Compared to wild type CASZ1b, K37 almost completely lost transcriptional activity at regulating all these genes in SY5Y cells (data are shown as means ± S.E.M., *: p<0.05). Compared to wild type CASZ1b, L37 significantly decreased transcriptional activity at regulating TH, NGFR and MYC, but had a slight increase at regulating CD9 and no effect on KIT (data are shown as means ± S.E.M., *: p<0.05).

    Journal: Oncogene

    Article Title: Identification of CASZ1 nuclear export signal (NES) reveals potential mechanisms for loss of CASZ1 tumor suppressor activity in neuroblastoma

    doi: 10.1038/onc.2016.179

    Figure Lengend Snippet: (A) IPA assay of CASZ1b targets in SY5Y cells determined by microarray showed gene enrichment in the categories of molecular and cellular functions with a key subcategory being cell growth and proliferation (threshold represents p=0.05). (B) GSEA assay indicated the positive enrichment of genes involved neurological system process (left panel), and negative enrichment of genes regulated by MYC (right panel). NES, normalized enrichment score; Nom, nominal; FDR, false discovery rate. (C) Transcriptional activity assay of cytoplasmic localized K37A mutant and loss of NuRD binding mutant L31A in SY5Y cells by realtime PCR. a, Left panel: western blot analysis of CASZ1b and mutant proteins from SY5YtetCASZ1b and CASZ1b mutant cells after 24 h Tet treatment; right panel: realtime PCR analysis of CASZ1b and mutant mRNA levels from SY5YtetCASZ1b and CASZ1b mutant cells after 24 h Tet treatment. b-f, realtime PCR result verified the regulation of TH, NGFR, CD9, MYC and KIT by CASZ1b in SY5Y cells after 24 h Tet treatment. Compared to wild type CASZ1b, K37 almost completely lost transcriptional activity at regulating all these genes in SY5Y cells (data are shown as means ± S.E.M., *: p<0.05). Compared to wild type CASZ1b, L37 significantly decreased transcriptional activity at regulating TH, NGFR and MYC, but had a slight increase at regulating CD9 and no effect on KIT (data are shown as means ± S.E.M., *: p<0.05).

    Article Snippet: Gene set enrich analysis (GSEA) ( , ) was performed using the whole gene list generated by uploading the raw microarray data to Partek Genomics Suite 6.6.

    Techniques: Microarray, Activity Assay, Mutagenesis, Binding Assay, Western Blot